**PBL Assay Science** is a biotechnology and life sciences startup that has been making strides in the field since its establishment in **1990**. The company's mission revolves around providing high-quality immunoassay products and biomarker testing services to various researchers and institutions across the globe. PBL's focus on developing specialty immunoassay products and leveraging its expertise in interferons and other cytokines has garnered the attention of multinational pharmaceutical companies, biotechnology firms, academic institutions, and research centers. The startup has positioned itself as a reliable manufacturer of **interferon and cytokine proteins** and antibodies, offering pre-packaged immunoassay kits known for their excellence. PBL's products have been extensively validated and utilized in influential research publications, highlighting their reliability and efficacy. Furthermore, the company actively engages with study leads and researchers, providing assay services to expedite **clinical studies** and internal R&D endeavors. PBL's expertise in biomarker assay development and testing services on advanced bioanalytical platforms further solidifies its position in the industry. Overall, PBL Assay Science's commitment to delivering high-quality solutions and fostering trust within the scientific community has positioned it as a key player in the biotechnology and life sciences sector, attracting attention from potential **investors** seeking opportunities in cutting-edge scientific advancements and innovative solutions.
There is no investment information
No recent news or press coverage available for PBL Assay Science.